Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

        Clinical Trials and Human Subject Protection

Good Clinical Practice Educational Materials Home
          Science & Research
          Science and Research Special Topics
          Clinical Trials and Human Subject Protection
          Good Clinical Practice Educational MaterialsClinical Trials and Human Subject Protection Good Clinical Practice Educational Materials
  	
        Share
    Post
    Linkedin

    Email
    PrintUseful References

**Belmont Report**
	Based on the work of the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (1974-1978), the Department of Health and Human Services (HHS) revised and expanded its regulations for the protection of human subjects, 45 CFR part 46, in the late 1970s and early 1980s. In 1978, the Commission’s report "Ethical Principles and Guidelines for the Protection of Human Subjects of Research" was published. It was named the Belmont Report, for the Belmont Conference Center, where the National Commission met when first drafting the report.
	**Bioethics Commissions - Papers**
	Over the years, various U.S. bioethics commissions and councils have advised the President of the United States on ethical issues related to advances in biomedical science and technology. As a public resource, the Bioethics Research Library at Georgetown University compiled a list of these former national bioethics commissions and their reports, including, where available, downloadable copies of the reports. Materials produced by the various U.S. bioethics commissions in this archive are government documents and in the public domain. Please note the source as https://bioethicsarchive.georgetown.edu/pcbe/.
	**Comparison of FDA and HHS Regulations**
	A chart comparing FDA's regulations for human subject protection with those of the Department of Health and Human Services.
	**Critical Path Initiative**
	The Critical Path Initiative (CPI), was launched in March 2004, as FDA's national strategy for transforming the way FDA-regulated medical products are developed, evaluated, and manufactured. The initiative carefully examined medical product development, and identified problems and potential solutions to the daunting task of ensuring that unprecedented breakthroughs in medical science are demonstrated to be safe and effective for patients as quickly and inexpensively as possible. Archived materials about the Critical Path Initiative includes the major report, "Innovation or Stagnation? Challenge and Opportunity on the Critical Path to New Medical Products."
	**E-Mail Messages**
	Copies of e-mail messages (including the original inquiry and associated reply(ies)) that have been submitted by the public to the Good Clinical Practice Program’s gcp.questions@fda.hhs.gov e-mail account. These e-mail messages have been redacted to the extent permitted by the Freedom of Information Act.
	**FDA and Clinical Drug Trials: A Short History**
	**GCP Training Information**
	**International Compilation of Human Research Standards** 
	The Office for Human Research Protections (OHRP), Department of Health and Human Services (HHS) maintains and updates this list of laws, regulations, and guidelines (collectively referred to as standards) that govern human subjects research in 130 countries, or which were developed by international and regional organizations. The most current version of the document is accessible at the link above.
	***Protecting America’s Health Through Human Drugs***
	This FDA publication, originally titled *From Test Tube to Patient: Improving Health Through Human Drugs*, tells the story of new drug development in the United States. Articles discuss various aspects of drug development--from test tube to medicine cabinet. This is an excellent primer for learning about the drug development and approval process.

                                                                                  Content current as of:
      01/27/2021Good Clinical Practice Educational Materials
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop